Log In
BCIQ
Print this Print this
 

Veltin Gel, clindamycin/tretinoin

Also known as: Velac

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionTopical 1.2% clindamycin and 0.025% tretinoin gel
Molecular Target Ribosomal 50S subunit
Mechanism of ActionProkaryotic protein synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat acne; Treat acne vulgaris
Regulatory Designation
PartnerAlmirall S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/23/2015

Undisclosed

Undisclosed

0

Get a free BioCentury trial today